Catalyst Pharmaceuticals Files 2024 10-K
Ticker: CPRX · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 10-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
Related Tickers: CPRX
TL;DR
Catalyst Pharma (CPRX) dropped its 2024 10-K. Full year financials and biz details inside.
AI Summary
Catalyst Pharmaceuticals, Inc. filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is headquartered in Coral Gables, Florida. Key financial details and operational highlights for the year are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Catalyst Pharmaceuticals' financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Catalyst faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-26 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-26 (date) — Filing date
- Coral Gables, FL (location) — Company headquarters
- Agamree (product) — Product mentioned in relation to royalty amounts
- Fycompa (product) — Product mentioned in relation to U.S. Rights
FAQ
What were the total sales revenues for Catalyst Pharmaceuticals in the fiscal year ending December 31, 2024?
The filing indicates sales revenue net for the period, but specific total dollar amounts for FY 2024 are not explicitly stated in the provided snippet. Further review of the full 10-K document is required.
What is the company's primary business address?
The company's business address is 355 Alhambra Circle, Suite 801, Coral Gables, FL 33134.
What is the Central Index Key (CIK) for Catalyst Pharmaceuticals, Inc.?
The Central Index Key for Catalyst Pharmaceuticals, Inc. is 0001369568.
What is the Standard Industrial Classification (SIC) code for Catalyst Pharmaceuticals?
The Standard Industrial Classification code for Catalyst Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 10-K report?
This 10-K report was filed on February 26, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).